STX4 Is Indispensable for Mitochondrial Homeostasis in Skeletal Muscle
Journal of Cachexia, Sarcopenia and Muscle · 2025
DOI: 10.1002/jcsm.70113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2025. Verfasst von Joseph M Hoolachan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Endocrinology, Arthur Riggs Diabetes and Metabolism Research Institute, City of Hope Beckman Research Institute,…. Hauptthemen laut MEDLINE: Muscle, Skeletal, Qa-SNARE Proteins, Mitochondria, Mitochondria, Muscle. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Background
Mitochondrial homeostasis is vital for optimal skeletal muscle integrity. Mitochondrial quality control (MQC) mechanisms that are essential for maintaining proper functions of mitochondria include mitochondrial biogenesis, dynamics and mitophagy. Previously, Syntaxin 4 (STX4), traditionally considered a cell surface protein known for glucose uptake in skeletal muscle, was also identified at the outer mitochondrial membrane. STX4 enrichment was sufficient to reverse Type 2 diabetes–associated mitochondrial damage in skeletal muscle by inactivation of mitochondrial fission. However, whether STX4 could modulate skeletal muscle mitochondrial homeostasis through MQC mechanisms involving mitochondrial biogenesis or mitophagy remains to be determined.
Methods
To determine the requirements of STX4 in mitochondrial structure, function and MQC processes of biogenesis and mitophagy, we implemented our in‐house generated inducible skeletal muscle‐specific STX4‐knockout (skmSTX4‐iKO) mice ( Stx4 fl/fl ; Tg (HSA‐rtTA/TRE‐Cre )/B6) and STX4‐depleted immortalized L6.GLUT4myc myotubes via siRNA knockdown (siSTX4).
Results
We found that non‐obese skmSTX4‐iKO male mice (> 50% reduced STX4 abundance, soleus and gastrocnemius *** p < 0.001, tibialis anterior (TA) **** p < 0.0001) developed insulin resistance (** p < 0.01), together with reduced energy expenditure (AUC * p < 0.05), respiratory exchange ratio (AUC ** p < 0.01) and grip strength (* p < 0.05). STX4 ablation in muscle also impaired mitochondrial oxygen consumption rate (**** p < 0.0001). Mitochondrial morphological damage was heterogenous in STX4‐depleted muscle, presenting with small fragmented mitochondria (**** p < 0.0001) and decreased electron transport chain (ETC) abundance (CI *** p < 0.001, CII * p < 0.05, CIV ** p < 0.01) in oxidative soleus muscle, whereas glycolytic‐rich TA fibres displayed enlarged swollen mitochondria (**** p < 0.0001) with no change in ETC abundance. Notably, > 60% reduction of STX4 in siSTX4 L6.GLUT4myc myotubes (**** p < 0.0001) also decreased ETC abundance (CI ** p < 0.01, CII *** p < 0.001, CIV ** p < 0.01) without changes in mitochondrial glucose metabolism, as shown by [U‐ 13 C]glucose isotope tracing. For MQC, both skmSTX4‐iKO male mice (* p < 0.05) and siSTX4 L6.GLUT4myc myotubes (* p < 0.05) showed decreased mitochondrial DNA levels alongside reduced mRNA expression of mitochondrial biogenesis genes Ppargc1a (PGC1‐α, * p < 0.05) and Tfam (* p < 0.05) in skmSTX4‐iKO soleus muscle and PGC1‐α (mRNA ** p < 0.01, protein * p < 0.05), NRF1 (mRNA ** p < 0.01 and protein * p < 0.05) and Tfam (mRNA * p < 0.05) in siSTX4 L6.GLUT4myc myotubes. Furthermore, live cell imaging using the mt‐Keima mitophagy biosensor in siSTX4 L6.GLUT4myc cells revealed significantly impaired mitochondrial turnover by mitophagy (* p < 0.05) and mitochondria–lysosome colocalization (* p < 0.05). STX4 depletion also reduced canonical mitophagy markers, PINK1 and PARKIN in both skmSTX4‐iKO muscle (PARKIN * p < 0.05, PINK1 ** p < 0.01) and siSTX4 L6.GLUT4myc myotubes (PARKIN ** p < 0.01, PINK1 * p < 0.05).
Conclusions
Our study demonstrated STX4 as a key mitochondrial regulator required for mitochondrial homeostasis in skeletal muscle.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Cellular Endocrinology, Arthur Riggs Diabetes and Metabolism Research Institute, City of Hope Beckman Research Institute, Duarte, California, USA.
- Amgen Inc, Thousand Oaks, California, USA.
- Sanegene Bio Inc., Suzhou, China.
- Comprehensive Metabolic Phenotyping Core, Beckman Research Institute, Duarte, California, USA.
- Clinical Research Division MC, City of Hope Beckman Research Institute, Duarte, California, USA.
- Department of Diabetes Complications and Metabolism, Arthur Riggs Diabetes and Metabolism Research Institute, City of Hope Beckman Research Institute, Duarte, California, USA.
ORCID-Profile: Debbie C Thurmond
Förderung
- NIDDK NIH HHS
- NIH HHS
- NCI NIH HHS
- American Heart Association
- National Institutes of Health
Zitieren
APA
Hoolachan, J. M., Balakrishnan, R., McCown, E. M., Merz, K. E., Zhou, C., Bloom-Saldana, E., Fueger, P. T., Hamilton, A., Kiperman, T., Ma, K., Oh, E., Jiang, L., Pirrotte, P., Shirihai, O., & Thurmond, D. C. (2025). STX4 Is Indispensable for Mitochondrial Homeostasis in Skeletal Muscle. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.70113
Vancouver
Hoolachan JM, Balakrishnan R, McCown EM, Merz KE, Zhou C, Bloom-Saldana E, et al. STX4 Is Indispensable for Mitochondrial Homeostasis in Skeletal Muscle. Journal of Cachexia, Sarcopenia and Muscle. 2025. doi:10.1002/jcsm.70113
BibTeX
@article{Hoolachan2025,
author = {Hoolachan, Joseph M and Balakrishnan, Rekha and McCown, Erika M and Merz, Karla E and Zhou, Chunxue and Bloom-Saldana, Elizabeth and Fueger, Patrick T and Hamilton, Angelica and Kiperman, Tali and Ma, Ke and Oh, Eunjin and Jiang, Lei and Pirrotte, Patrick and Shirihai, Orian and Thurmond, Debbie C},
title = {STX4 Is Indispensable for Mitochondrial Homeostasis in Skeletal Muscle},
journal = {Journal of Cachexia, Sarcopenia and Muscle},
year = {2025},
doi = {10.1002/jcsm.70113}
}
EUVIMED